Daily Reporter

Are we reaching a turning point in metastatic prostate cancer?

At yesterday’s Presidential Symposium, a Late-Breaking Abstract presentation of the PROfound study reported a clinically meaningful benefit in radiological progression-free survival (PFS) with olaparib in men with BRCA1, BRCA2 or ATM mutations in metastatic castration-resistant…

Read More

‘Living’ anticancer medicines: has a new era started?

The benefits of adoptive T-cell therapy—where T-cells are given to induce a specific immune response—are moving closer to reality for patients with solid tumours. Studies presented at ESMO Congress 2019 over the past few days…

Read More




Let’s talk about cancer pain

Is pain a consequence of tumour growth or a signal that treatments are not effective? Should I ever find relief from it? Or should I tolerate it? These are some of the most frequently asked…

Read More

Slow progress on female leadership in oncology

“Gender-related issues are not only of interest to female professionals, but the whole oncology community would benefit from ensuring a level playing field,” says Prof. Solange Peters from Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland,…

Read More